Sudo Biosciences Funding: $188M Raised, Series B (2024)
Sudo Biosciences is based in Carmel, IN. It has raised $188M in total funding. Latest round: Series B. Backed by Enavate Sciences, TPG, Sanofi Ventures.
Sudo Biosciences funding overview
Sudo Biosciences is based in Carmel, IN. Sudo Biosciences has raised $188M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2024. The round record for Sudo Biosciences runs through 2024; nothing later has been disclosed. Investors on record include Enavate Sciences, TPG, Sanofi Ventures, Frazier Life Sciences, Surveyor Capital, Monograph Capital and 5 others. 11 distinct backers are named across the disclosed rounds.
Sudo Biosciences at a glance
Total raised
$188M
Latest round
Series B
Latest round date
January 2024
Headquarters
Carmel, IN
Notable investors
Enavate Sciences, TPG, Sanofi Ventures, Frazier Life Sciences, Surveyor Capital, Monograph Capital, Eventide Asset Management, Velosity Capital
Frequently asked about Sudo Biosciences funding
How much has Sudo Biosciences raised?
Sudo Biosciences has raised $188M in total disclosed funding across the rounds on record.
Who has invested in Sudo Biosciences?
Enavate Sciences, TPG, Sanofi Ventures, Frazier Life Sciences, Surveyor Capital, Monograph Capital are named among the investors backing Sudo Biosciences.
What was the latest Sudo Biosciences funding round?
The most recent disclosed round is a Series B, announced in January 2024.
Where is Sudo Biosciences based?
Sudo Biosciences is based in Carmel, IN.
When did Sudo Biosciences last raise?
The last disclosed Sudo Biosciences round closed in January 2024 at Series B.
Round data for Sudo Biosciences is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Carmel and backer lists below.
